Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.

Current gene therapy - 1 Jan 2024

Bhushan Bharat, Singh Kuldeep, Kumar Shivendra, Bhardwaj Anjali

Abstract excerpt

Neurodegenerative disorders pose significant challenges in the realm of healthcare, as these conditions manifest in complex, multifaceted ways, often attributed to genetic anomalies. With the emergence of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology, a new frontier has been unveiled in the quest for targeted, precise genetic manipulation. This abstract explores the recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Clustered Regularly Interspaced Short Palindromic Repeats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CRISPR-Cas Systems

Share to Gene Editing

Share to Genetic Therapy

Share to Huntington Disease

Share to Neurodegenerative Diseases

Share to Parkinson Disease

Source

Identifiers

PMID: 38738727
DOI: 10.2174/0115665232292246240426125504

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.PMID 38738727Read ↗

Application of CRISPR/Cas9 in the management of Alzheimer’s disease and Parkinson’s disease: a reviewSemantic proximity Read ↗

Application of CRISPR genetic screens to investigate neurological diseasesSemantic proximity Read ↗

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeuticsSemantic proximity Read ↗

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential.Semantic proximity Read ↗

CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.Semantic proximity Read ↗

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.Semantic proximity Read ↗

Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders.Semantic proximity Read ↗

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision MedicineSemantic proximity Read ↗

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicineSemantic proximity Read ↗

Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications.Semantic proximity Read ↗

CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genesSemantic proximity Read ↗

CRISPR-Cas9 for treating hereditary diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.